The 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS)

第四届国际细胞因子和干扰素学会（ICIS）年会将在旧金山举行 弗朗西斯科，加州，凯悦酒店，2016年10月16日至10月19日。本国际 会议将汇集细胞因子信号传导和生物学，免疫学， 癌症研究、新陈代谢和传染病。本次会议的共同主席是大卫阿蒂斯博士 （康奈尔大学），约翰·奥谢博士（国家卫生研究院），埃里卡皮尔斯博士（马克斯·普朗克）;这些科学家一起涵盖了一个 与ICIS利益相关的广泛的科学专业知识，并具有出色的工作能力。 作为一个群体的关系。会议的一个主要目标将是促进科学家之间的互动 专注于细胞因子信号传导和生物学不同领域的功能，如宿主-微生物群相互作用， 天然免疫，宿主防御，全身代谢的免疫调节，免疫细胞代谢 细胞，原发性免疫缺陷和表观遗传学-以及这些如何转化为新兴疗法。另一 这次会议的目的是促进年轻的研究人员和学员之间的互动， 干扰素和细胞因子领域的研究人员。优秀的初级研究人员、博士后研究人员， 将鼓励研究生/医科学生参与，并将向年轻的研究人员颁发奖项， 如本提案正文所述，这些类别中的每一个类别。除了约34名受邀 发言人（一些插槽仍然开放给最后打破发言人）定于全体会议和专题讨论会， 报名者提交的一些摘要将被选为专题口头报告 Sessions.将特别注意让初级调查员有机会介绍他们的工作 在这些会议期间。欢迎多达300名参加者提交海报，并将有机会 讨论他们的作品该计划包括来自学术机构的科学家， 以及生物技术和制药公司。我们特别注意确保 该计划在性别、种族、资历和地理位置方面都很平衡。一项特别的努力将是 为支持代表性不足的少数民族和妇女的职业发展， 2016年的会议将有2个讲习班和一个专门为学员和年轻人（第一年）举办的特别招待会 教师，旨在促进这些互动。这是联合主席和科学组织的坚定信念 委员会（由来自8个国家的17名科学家组成，包括7名女性和2名统一资源管理员）， 这次会议将汇集细胞因子研究各个领域的领导者、初级研究人员和学员， 启发重要的新的调查途径，将极大地有利于职业发展， 在细胞因子领域有前途的年轻研究人员和学员。

The 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS) will be held in San Francisco, California at the Hyatt Regency Hotel from October 16 - October 19, 2016. This international conference will bring together leading investigators in the fields of cytokine signaling and biology, immunology, cancer research, metabolism, and infectious diseases. The Co-Chairs for this meeting are Dr. David Artis (Cornell University), Dr. John O'Shea (NIH), Dr. Erika Pearce (Max Planck); together, these scientists cover a broad spectrum of scientific expertise relevant to the interests of the ICIS, and have an excellent working relationship as a group. A major goal of the meeting will be to promote the interactions between scientists focusing on cytokine signaling and function in diverse areas of biology, such as host-microbiota interactions, innate immunity, host defense, immune regulation of whole body metabolism, cellular metabolism in immune cells, primary immunodeficiencies, and epigenetics – and how these translate into emerging therapies. Another goal of this meeting is to facilitate interactions between young investigators and trainees with established researchers in the interferon and cytokine field. Outstanding junior investigators, postdoctoral researchers, and graduate/medical students will be encouraged to participate, and awards will be given to young researchers in each of these categories, as described in the body of this proposal. In addition to approximately 34 invited speakers (some slots remain open for late-breaking speakers) scheduled for Plenary Sessions and Symposia, a number of abstracts submitted by registrants will be selected for oral presentations in Special Topics Sessions. Particular attention will be paid to giving junior investigators an opportunity to present their work during these sessions. Up to 300 participants are welcome to present a poster and will be given the opportunity to discuss their work during their poster session. The program includes scientists from academic institutions, as well as from biotechnology and pharmaceutical companies. We have paid special attention to ensure a program that is well-balanced by gender, ethnicity, seniority and geographic location. A special effort will be made to support the career development of under-represented minorities and women, and an important part of the 2016 meeting is to have 2 workshops and a special reception exclusively for trainees and young (1st year) faculty, designed to foster these interactions. It is the firm belief of the Co-Chairs and Scientific Organizing Committee (composed of 17 scientists from 8 countries including 7 females and two URMs) that, by bringing together leaders, junior investigators, and trainees in these diverse areas of cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine field.